BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38166392)

  • 1. Identification of a Sonically Activated Degrader of Methionine Adenosyltransferase 2A by an
    He H; Wang Z; Peng X; Qing L; Zhang Y; Fu S; Xu J; Li Y; Zhang S
    J Med Chem; 2024 Jan; 67(1):543-554. PubMed ID: 38166392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer.
    Tomasi ML; Ryoo M; Skay A; Tomasi I; Giordano P; Mato JM; Lu SC
    Exp Cell Res; 2013 Jul; 319(12):1902-1911. PubMed ID: 23588207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and Structural Optimization of Methionine Adenosyltransferase 2A (MAT2A) Inhibitors with High In Vivo Potency and Oral Bioavailability.
    Zhang S; Qing L; Wang Z; Zhang Y; Li Y; Fang H; Liu Y; He H
    J Med Chem; 2023 Apr; 66(7):4849-4867. PubMed ID: 36961373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of Methionine Adenosyltransferase 2A (MAT2A) as an Anticancer Target: Structure, Function, and Inhibitors.
    Li C; Gui G; Zhang L; Qin A; Zhou C; Zha X
    J Med Chem; 2022 Jul; 65(14):9531-9547. PubMed ID: 35796517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells.
    Chen H; Xia M; Lin M; Yang H; Kuhlenkamp J; Li T; Sodir NM; Chen YH; Josef-Lenz H; Laird PW; Clarke S; Mato JM; Lu SC
    Gastroenterology; 2007 Jul; 133(1):207-18. PubMed ID: 17631143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A.
    Quinlan CL; Kaiser SE; Bolaños B; Nowlin D; Grantner R; Karlicek-Bryant S; Feng JL; Jenkinson S; Freeman-Cook K; Dann SG; Wang X; Wells PA; Fantin VR; Stewart AE; Grant SK
    Nat Chem Biol; 2017 Jul; 13(7):785-792. PubMed ID: 28553945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells: role of S-adenosylmethionine.
    Martínez-Chantar ML; Latasa MU; Varela-Rey M; Lu SC; García-Trevijano ER; Mato JM; Avila MA
    J Biol Chem; 2003 May; 278(22):19885-90. PubMed ID: 12660248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
    Maldonado LY; Arsene D; Mato JM; Lu SC
    Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis.
    Wang X; Guo X; Yu W; Li C; Gui Y; Cai Z
    BMC Cancer; 2014 Mar; 14():196. PubMed ID: 24636201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability of cancer stem cells.
    Strekalova E; Malin D; Weisenhorn EMM; Russell JD; Hoelper D; Jain A; Coon JJ; Lewis PW; Cryns VL
    Breast Cancer Res Treat; 2019 May; 175(1):39-50. PubMed ID: 30712196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer.
    Yang H; Huang ZZ; Zeng Z; Chen C; Selby RR; Lu SC
    Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G184-90. PubMed ID: 11208539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis.
    Vázquez-Chantada M; Fernández-Ramos D; Embade N; Martínez-Lopez N; Varela-Rey M; Woodhoo A; Luka Z; Wagner C; Anglim PP; Finnell RH; Caballería J; Laird-Offringa IA; Gorospe M; Lu SC; Mato JM; Martínez-Chantar ML
    Gastroenterology; 2010 May; 138(5):1943-53. PubMed ID: 20102719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.
    Tomasi ML; Ryoo M; Ramani K; Tomasi I; Giordano P; Mato JM; Lu SC
    Oncotarget; 2015 Nov; 6(35):37706-23. PubMed ID: 26416353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC1-independent translation control in mammalian cells by methionine adenosyltransferase 2A and S-adenosylmethionine.
    Alam M; Shima H; Matsuo Y; Long NC; Matsumoto M; Ishii Y; Sato N; Sugiyama T; Nobuta R; Hashimoto S; Liu L; Kaneko MK; Kato Y; Inada T; Igarashi K
    J Biol Chem; 2022 Jul; 298(7):102084. PubMed ID: 35636512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production.
    Liu Q; Chen J; Liu L; Zhang J; Wang D; Ma L; He Y; Liu Y; Liu Z; Wu J
    J Biol Chem; 2011 May; 286(19):17168-80. PubMed ID: 21247894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel MAT2A inhibitors by an allosteric site-compatible fragment growing approach.
    Gao F; Ding X; Cao Z; Zhu W; Fan Y; Steurer B; Wang H; Cai X; Zhang M; Aliper A; Ren F; Ding X; Zhavoronkov A
    Bioorg Med Chem; 2024 Feb; 100():117633. PubMed ID: 38342078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorinated N,N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A.
    Zhang W; Sviripa V; Chen X; Shi J; Yu T; Hamza A; Ward ND; Kril LM; Vander Kooi CW; Zhan CG; Evers BM; Watt DS; Liu C
    ACS Chem Biol; 2013 Apr; 8(4):796-803. PubMed ID: 23363077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition.
    Bedard GT; Gilaj N; Peregrina K; Brew I; Tosti E; Shaffer K; Tyler PC; Edelmann W; Augenlicht LH; Schramm VL
    J Biol Chem; 2024 Jan; 300(1):105492. PubMed ID: 38000655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
    Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.